Literature DB >> 3244622

In vitro model for ciclosporin intestinal absorption in lipid vehicles.

J P Reymond1, H Sucker.   

Abstract

The influence of lipid vehicles on the intestinal absorption of Ciclosporin was studied in vitro. The effect of the intestinal lipid digestion was considered on the partition of the drug from olive oil or middle-chain triglyceride (MCT) into phases of simulated intestinal content. The phases obtained after ultracentrifugation were analyzed for their Ciclosporin content and characterized for their lipid classes. For both lipid vehicles the presence of lipolysis products did not promote the partition of the drug into the aqueous phase. The absorption in vivo was not related to the drug amount in the aqueous phase and in the oil phase. Therefore, phase quantification in vitro cannot simulate the dynamics of in vivo absorption events following application of a poorly water-soluble drug in a lipid vehicle.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244622     DOI: 10.1023/a:1015987223407

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Mechanism of the intestinal absorption of drugs from oil-in-water emulsions. VI. Absorption of lipid-soluble dyes from tributyrin and triolein emulsions in rat small intestine.

Authors:  T Noguchi; C Takahashi; T Kimura; S Muranishi; H Sezaki
Journal:  Chem Pharm Bull (Tokyo)       Date:  1975-04       Impact factor: 1.645

Review 2.  The micellar hypothesis of fat absorption: must it be revisited?

Authors:  B Borgström
Journal:  Scand J Gastroenterol       Date:  1985-05       Impact factor: 2.423

3.  The effect of different oils on the absorption of probucol in the rat.

Authors:  K J Palin; C G Wilson
Journal:  J Pharm Pharmacol       Date:  1984-09       Impact factor: 3.765

4.  The effect of oils on the lymphatic absorption of DDT.

Authors:  K J Palin; C G Wilson; S S Davis; A J Phillips
Journal:  J Pharm Pharmacol       Date:  1982-11       Impact factor: 3.765

Review 5.  Lipid digestion and absorption.

Authors:  M C Carey; D M Small; C M Bliss
Journal:  Annu Rev Physiol       Date:  1983       Impact factor: 19.318

6.  Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites.

Authors:  G Maurer; H R Loosli; E Schreier; B Keller
Journal:  Drug Metab Dispos       Date:  1984 Jan-Feb       Impact factor: 3.922

7.  Watching fat digestion.

Authors:  J S Patton; M C Carey
Journal:  Science       Date:  1979-04-13       Impact factor: 47.728

8.  Distinct effects of three bile salts on cholesterol solubilization by oleate-monoolein-bile salt micelles.

Authors:  J C Montet; M O Reynier; A M Montet; A Gerolami
Journal:  Biochim Biophys Acta       Date:  1979-11-21

9.  Rat lingual lipase: partial purification, hydrolytic properties, and comparison with pancreatic lipase.

Authors:  I M Roberts; R K Montgomery; M C Carey
Journal:  Am J Physiol       Date:  1984-10

10.  In situ intestinal absorption of a poorly water-soluble drug from mixed micellar solutions of bile salt and lipolysis products in rats.

Authors:  A T Serajuddin; M Rosoff; A H Goldberg
Journal:  Pharm Res       Date:  1985-09       Impact factor: 4.200

View more
  7 in total

1.  Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.

Authors:  Jean F Cuiné; William N Charman; Colin W Pouton; Glenn A Edwards; Christopher J H Porter
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

2.  Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering.

Authors:  Dimitrios G Fatouros; G Roshan Deen; Lise Arleth; Bjorn Bergenstahl; Flemming Seier Nielsen; Jan Skov Pedersen; Anette Mullertz
Journal:  Pharm Res       Date:  2007-04-26       Impact factor: 4.200

3.  In vivo model for ciclosporin intestinal absorption in lipid vehicles.

Authors:  J P Reymond; H Sucker; J Vonderscher
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

4.  Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.

Authors:  Christopher J H Porter; Ann Marie Kaukonen; Ben J Boyd; Glenn A Edwards; William N Charman
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

5.  Lipid-based formulations for danazol containing a digestible surfactant, Labrafil M2125CS: in vivo bioavailability and dynamic in vitro lipolysis.

Authors:  Anne Larsen; René Holm; Mette Lund Pedersen; Anette Müllertz
Journal:  Pharm Res       Date:  2008-07-01       Impact factor: 4.200

6.  Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations.

Authors:  Ann Marie Kaukonen; Ben J Boyd; Christopher J H Porter; William N Charman
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

Review 7.  Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations.

Authors:  Sivacharan Kollipara; Rajesh Kumar Gandhi
Journal:  Acta Pharm Sin B       Date:  2014-10-08       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.